Released: 03/27/2023 Expires: 03/31/2024 (subject to change)
CE for this activity will not be available after this date.
Overview: Alcohol use disorder (AUD) is a medical condition characterized by a problematic patterns of alcohol consumption that lead to compulsive drinking and loss of control of alcohol use. According to data from the 2019 National Survey on Drug Use and Health, more than 14.5 million people 12 yrs and older in the United States met the clinical criteria for AUD, and more than 1 in 4 adults over 18 years of age reported at least one episode of binge drinking within the previous 90 days. This is a treatable disease and can be safely managed or have treatment initiated by most advanced practice providers.
Objectives After this presentation the learner will be able to:
Identify strategies to reduce alcohol-related stigma in screening, diagnosis, and management.
Evaluate validated screening tools for the identification of AUD and problematic alcohol use.
Develop personalized pharmacological and nonpharmacological treatment plans for AUD.
Integrate strategies to reduce patient, provider, and institutional barriers to AUD care.
Speakers Laura G Leahy, DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP, FAAN Colleen Barry, MSN, APRN, FNP-C, CARN-AP, CSAP
Disclosure This program was planned in accordance with AANP CE Standards and Policies. Colleen and Laura have no relevant financial relationships to disclose. All Planners involved in this activity have no relevant financial relationships to disclose.
Supported by an independent medical education grant from Alkermes, Inc.
Disclaimer Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete the educational content:
Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
Click on the Additional Resources button to review all additional materials provided (slide handouts and any other downloadable resources).
After completing all content, click on the blue Next Steps button:
Submit the evaluation to receive full AANP CE/Rx credit.
Note: This multi-module series allows learners to select the modules that they want to complete in any order that they want to complete them in. CE/Rx credit and a completion certificate will be awarded for EACH module that is completed.
Additional Information For questions or more information concerning this online CE activity,please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
2.29 Contact Hour(s) of CE, 0.67 of which may be applied towards Pharmacology